Report Detail

Pharma & Healthcare Global Electrocompetent Cells Market Insights, Forecast to 2025

  • RnM2441237
  • |
  • 12 April, 2019
  • |
  • Global
  • |
  • 124 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

The global Electrocompetent Cells market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Electrocompetent Cells market based on company, product type, end user and key regions.

This report studies the global market size of Electrocompetent Cells in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Electrocompetent Cells in these regions.
This research report categorizes the global Electrocompetent Cells market by top players/brands, region, type and end user. This report also studies the global Electrocompetent Cells market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Takara Bio
Promega Corporation
Beijing TransGen Biotech
GeneScript Corporation
Yeastern Biotech
New England Biolabs
QIAGEN N.V.
OriGene Technologies
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Delphi Genetics
IBA GmBH
Cell Applications
BioDynamics Laboratory
Scarab Genomics

Market size by Product
Cloned Competent Cells
Agrobacterium tumefaciens Competent Cells
Expression Competent Cells
Market size by End User
Subcloning & Routine Cloning
Phage Display Library Construction
Toxic/Unstable Dna Cloning
High-Throughput Cloning
Protein Expression
Mutagenesis
Single-Stranded Dna Production
Bacmid creation
Cre-lox recombination (PIR1/PIR2)

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Electrocompetent Cells market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Electrocompetent Cells market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Electrocompetent Cells companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Electrocompetent Cells submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Electrocompetent Cells are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Electrocompetent Cells market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Study Coverage

    • 1.1 Electrocompetent Cells Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Electrocompetent Cells Market Size Growth Rate by Product
      • 1.4.2 Cloned Competent Cells
      • 1.4.3 Agrobacterium tumefaciens Competent Cells
      • 1.4.4 Expression Competent Cells
    • 1.5 Market by End User
      • 1.5.1 Global Electrocompetent Cells Market Size Growth Rate by End User
      • 1.5.2 Subcloning & Routine Cloning
      • 1.5.3 Phage Display Library Construction
      • 1.5.4 Toxic/Unstable Dna Cloning
      • 1.5.5 High-Throughput Cloning
      • 1.5.6 Protein Expression
      • 1.5.7 Mutagenesis
      • 1.5.8 Single-Stranded Dna Production
      • 1.5.9 Bacmid creation
      • 1.5.10 Cre-lox recombination (PIR1/PIR2)
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Electrocompetent Cells Market Size
      • 2.1.1 Global Electrocompetent Cells Revenue 2014-2025
      • 2.1.2 Global Electrocompetent Cells Sales 2014-2025
    • 2.2 Electrocompetent Cells Growth Rate by Regions
      • 2.2.1 Global Electrocompetent Cells Sales by Regions
      • 2.2.2 Global Electrocompetent Cells Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Electrocompetent Cells Sales by Manufacturers
      • 3.1.1 Electrocompetent Cells Sales by Manufacturers
      • 3.1.2 Electrocompetent Cells Sales Market Share by Manufacturers
      • 3.1.3 Global Electrocompetent Cells Market Concentration Ratio (CR5 and HHI)
    • 3.2 Electrocompetent Cells Revenue by Manufacturers
      • 3.2.1 Electrocompetent Cells Revenue by Manufacturers (2014-2019)
      • 3.2.2 Electrocompetent Cells Revenue Share by Manufacturers (2014-2019)
    • 3.3 Electrocompetent Cells Price by Manufacturers
    • 3.4 Electrocompetent Cells Manufacturing Base Distribution, Product Types
      • 3.4.1 Electrocompetent Cells Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Electrocompetent Cells Product Type
      • 3.4.3 Date of International Manufacturers Enter into Electrocompetent Cells Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Electrocompetent Cells Sales by Product
    • 4.2 Global Electrocompetent Cells Revenue by Product
    • 4.3 Electrocompetent Cells Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Electrocompetent Cells Breakdown Data by End User

    6 North America

    • 6.1 North America Electrocompetent Cells by Countries
      • 6.1.1 North America Electrocompetent Cells Sales by Countries
      • 6.1.2 North America Electrocompetent Cells Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Electrocompetent Cells by Product
    • 6.3 North America Electrocompetent Cells by End User

    7 Europe

    • 7.1 Europe Electrocompetent Cells by Countries
      • 7.1.1 Europe Electrocompetent Cells Sales by Countries
      • 7.1.2 Europe Electrocompetent Cells Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Electrocompetent Cells by Product
    • 7.3 Europe Electrocompetent Cells by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Electrocompetent Cells by Countries
      • 8.1.1 Asia Pacific Electrocompetent Cells Sales by Countries
      • 8.1.2 Asia Pacific Electrocompetent Cells Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Electrocompetent Cells by Product
    • 8.3 Asia Pacific Electrocompetent Cells by End User

    9 Central & South America

    • 9.1 Central & South America Electrocompetent Cells by Countries
      • 9.1.1 Central & South America Electrocompetent Cells Sales by Countries
      • 9.1.2 Central & South America Electrocompetent Cells Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Electrocompetent Cells by Product
    • 9.3 Central & South America Electrocompetent Cells by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Electrocompetent Cells by Countries
      • 10.1.1 Middle East and Africa Electrocompetent Cells Sales by Countries
      • 10.1.2 Middle East and Africa Electrocompetent Cells Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Electrocompetent Cells by Product
    • 10.3 Middle East and Africa Electrocompetent Cells by End User

    11 Company Profiles

    • 11.1 Merck KGaA
      • 11.1.1 Merck KGaA Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Merck KGaA Electrocompetent Cells Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Merck KGaA Electrocompetent Cells Products Offered
      • 11.1.5 Merck KGaA Recent Development
    • 11.2 Thermo Fisher Scientific
      • 11.2.1 Thermo Fisher Scientific Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Thermo Fisher Scientific Electrocompetent Cells Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Thermo Fisher Scientific Electrocompetent Cells Products Offered
      • 11.2.5 Thermo Fisher Scientific Recent Development
    • 11.3 Agilent Technologies
      • 11.3.1 Agilent Technologies Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Agilent Technologies Electrocompetent Cells Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Agilent Technologies Electrocompetent Cells Products Offered
      • 11.3.5 Agilent Technologies Recent Development
    • 11.4 Takara Bio
      • 11.4.1 Takara Bio Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Takara Bio Electrocompetent Cells Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Takara Bio Electrocompetent Cells Products Offered
      • 11.4.5 Takara Bio Recent Development
    • 11.5 Promega Corporation
      • 11.5.1 Promega Corporation Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Promega Corporation Electrocompetent Cells Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Promega Corporation Electrocompetent Cells Products Offered
      • 11.5.5 Promega Corporation Recent Development
    • 11.6 Beijing TransGen Biotech
      • 11.6.1 Beijing TransGen Biotech Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Beijing TransGen Biotech Electrocompetent Cells Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Beijing TransGen Biotech Electrocompetent Cells Products Offered
      • 11.6.5 Beijing TransGen Biotech Recent Development
    • 11.7 GeneScript Corporation
      • 11.7.1 GeneScript Corporation Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 GeneScript Corporation Electrocompetent Cells Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 GeneScript Corporation Electrocompetent Cells Products Offered
      • 11.7.5 GeneScript Corporation Recent Development
    • 11.8 Yeastern Biotech
      • 11.8.1 Yeastern Biotech Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Yeastern Biotech Electrocompetent Cells Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Yeastern Biotech Electrocompetent Cells Products Offered
      • 11.8.5 Yeastern Biotech Recent Development
    • 11.9 New England Biolabs
      • 11.9.1 New England Biolabs Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 New England Biolabs Electrocompetent Cells Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 New England Biolabs Electrocompetent Cells Products Offered
      • 11.9.5 New England Biolabs Recent Development
    • 11.10 QIAGEN N.V.
      • 11.10.1 QIAGEN N.V. Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 QIAGEN N.V. Electrocompetent Cells Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 QIAGEN N.V. Electrocompetent Cells Products Offered
      • 11.10.5 QIAGEN N.V. Recent Development
    • 11.11 OriGene Technologies
    • 11.12 Lucigen
    • 11.13 Zymo Research
    • 11.14 Bio-Rad Laboratories
    • 11.15 Bioline
    • 11.16 Delphi Genetics
    • 11.17 IBA GmBH
    • 11.18 Cell Applications
    • 11.19 BioDynamics Laboratory
    • 11.20 Scarab Genomics

    12 Future Forecast

    • 12.1 Electrocompetent Cells Market Forecast by Regions
      • 12.1.1 Global Electrocompetent Cells Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Electrocompetent Cells Revenue Forecast by Regions 2019-2025
    • 12.2 Electrocompetent Cells Market Forecast by Product
      • 12.2.1 Global Electrocompetent Cells Sales Forecast by Product 2019-2025
      • 12.2.2 Global Electrocompetent Cells Revenue Forecast by Product 2019-2025
    • 12.3 Electrocompetent Cells Market Forecast by End User
    • 12.4 North America Electrocompetent Cells Forecast
    • 12.5 Europe Electrocompetent Cells Forecast
    • 12.6 Asia Pacific Electrocompetent Cells Forecast
    • 12.7 Central & South America Electrocompetent Cells Forecast
    • 12.8 Middle East and Africa Electrocompetent Cells Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Electrocompetent Cells Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Summary:
      Get latest Market Research Reports on Electrocompetent Cells . Industry analysis & Market Report on Electrocompetent Cells is a syndicated market report, published as Global Electrocompetent Cells Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Electrocompetent Cells market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,116.10
      4,674.15
      6,232.20
      3,623.10
      5,434.65
      7,246.20
      607,542.00
      911,313.00
      1,215,084.00
      325,806.00
      488,709.00
      651,612.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report